Skip to main content

Table 3 Commonly prescribed medications in patients with AF attending GUH, 2017 (N = 159)

From: Poor outcomes associated with antithrombotic undertreatment in patients with atrial fibrillation attending Gondar University Hospital: a retrospective cohort study

 

All patients N = 159

Potential Undertreatment N = 103

According to guideline treatment N = 56

ASA

66 (41.5%)

39 (37.9%)

27 (48.2%)

Warfarin

53 (33.3%)

1 (1.0%)

52 (92.9%)

Clopidogrel

5 (3.1%)

3 (2.9%)

2 (3.6%)

Digoxin

74 (46.5%)

43 (41.7%)

30 (53.6%)

Atenolol

58 (36.5%)

29 (28.2%)

29 (51.8%)

Metoprolol

17 (10.7%)

8 (7.8%)

9 (16.1%)

Carvedilol

2 (1.3%)

2 (1.9%)

0 (0%)

Propranolol

10 (6.3%)

8 (7.8%)

2 (3.6%)

Simvastatin

21 (13.2%)

12 (11.7%)

9 (16.1%)

Atorvastatin

20 (12.6%)

10 (9.7%)

10 (17.9%)

Captopril

1 (0.6%)

0 (0%)

1 (1.8%)

Enalapril

33 (20.8%)

17 (16.5%)

16 (28.6%)

Furosemide

89 (56.0%)

53 (51.5%)

36 (64.3%)

Spironolactone

72 (45.3%)

43 (41.7%)

29 (51.8%)

Hydrochlorothiazide

14 (8.8%)

9 (8.7%)

5 (8.9%)

Nifedipine/amlodipine

3 (1.9%)

2 (1.9%)

1 (1.8%)

Monthly benzathine penicillin

17 (10.7%)

3 (2.9%)

14 (25.0%)

PTU

19 (11.9%)

12 (11.7%)

7 (12.5%)